BRPI1008173A2 - "derivados de piridina espiroindolinona" - Google Patents

"derivados de piridina espiroindolinona"

Info

Publication number
BRPI1008173A2
BRPI1008173A2 BRPI1008173A BRPI1008173A BRPI1008173A2 BR PI1008173 A2 BRPI1008173 A2 BR PI1008173A2 BR PI1008173 A BRPI1008173 A BR PI1008173A BR PI1008173 A BRPI1008173 A BR PI1008173A BR PI1008173 A2 BRPI1008173 A2 BR PI1008173A2
Authority
BR
Brazil
Prior art keywords
spiroindolinone
pyridine derivatives
pyridine
derivatives
spiroindolinone pyridine
Prior art date
Application number
BRPI1008173A
Other languages
English (en)
Inventor
Li Chen
Song Yang
Xingchun Han
Zhuming Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI1008173A2 publication Critical patent/BRPI1008173A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI1008173A 2009-02-10 2010-02-02 "derivados de piridina espiroindolinona" BRPI1008173A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15127909P 2009-02-10 2009-02-10
PCT/EP2010/051252 WO2010091979A1 (en) 2009-02-10 2010-02-02 Spiroindolinone pyridine derivative

Publications (1)

Publication Number Publication Date
BRPI1008173A2 true BRPI1008173A2 (pt) 2016-03-01

Family

ID=41820540

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008173A BRPI1008173A2 (pt) 2009-02-10 2010-02-02 "derivados de piridina espiroindolinona"

Country Status (12)

Country Link
US (1) US7928233B2 (pt)
EP (1) EP2396326A1 (pt)
JP (1) JP2012512849A (pt)
KR (1) KR20110100678A (pt)
CN (1) CN102264738A (pt)
AU (1) AU2010212995A1 (pt)
BR (1) BRPI1008173A2 (pt)
CA (1) CA2751243A1 (pt)
IL (1) IL213466A0 (pt)
MX (1) MX2011007886A (pt)
SG (1) SG173591A1 (pt)
WO (1) WO2010091979A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104876938A (zh) 2009-11-12 2015-09-02 密歇根大学董事会 螺-吲哚酮mdm2拮抗剂
PE20140408A1 (es) 2010-11-12 2014-04-10 Univ Michigan Derivados espiro-oxindol como antagonistas de mdm2
TR201807311T4 (tr) 2011-03-10 2018-06-21 Daiichi Sankyo Co Ltd Dispiropirolidin derivesi.
MX346375B (es) 2011-05-11 2017-03-16 Univ Michigan Regents Antagonistas de espiro-oxindol de mdm2.
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
JP6564449B2 (ja) 2015-02-20 2019-08-21 第一三共株式会社 がんの併用治療法
KR20170134462A (ko) 2015-04-13 2017-12-06 다이이찌 산쿄 가부시키가이샤 Mdm2 저해제와 btk 저해제의 병용 치료법
CN109152843A (zh) 2016-05-20 2019-01-04 豪夫迈·罗氏有限公司 Protac抗体缀合物及其使用方法
US20190240210A1 (en) 2016-10-17 2019-08-08 Daiichi Sankyo Company, Limited Treatment Method by Combined Use of MDM2 Inhibitor and DNA Methyltransferase Inhibitor
WO2022183006A1 (en) 2021-02-25 2022-09-01 Mayo Foundation For Medical Education And Research Compounds for programmable protein degradation and methods of use for the disease treatment
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714473A1 (de) 1987-04-30 1988-11-10 Basf Ag Kontinuierliches verfahren zur epimerisierung von zuckern, insbesondere von d-arabinose zu d-ribose
EP0947511A1 (en) 1998-03-30 1999-10-06 F. Hoffmann-La Roche Ag Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
JP2003505388A (ja) 1999-07-21 2003-02-12 アストラゼネカ・アクチエボラーグ 新規化合物
EP1664050B1 (en) * 2003-09-03 2015-12-09 Neuren Pharmaceuticals Limited Neuroprotective bicyclic compounds and pharmaceutical compositions containing them
AU2006216780B8 (en) 2005-02-22 2010-04-22 The Regents Of The University Of Michigan Small molecule inhibitors of MDM2 and uses thereof
US7576082B2 (en) * 2005-06-24 2009-08-18 Hoffman-La Roche Inc. Oxindole derivatives
US20070213341A1 (en) * 2006-03-13 2007-09-13 Li Chen Spiroindolinone derivatives
US7495007B2 (en) * 2006-03-13 2009-02-24 Hoffmann-La Roche Inc. Spiroindolinone derivatives
DE602007011902D1 (de) 2006-03-13 2011-02-24 Hoffmann La Roche Spiroindolinon-derivate
WO2008005268A1 (en) 2006-06-30 2008-01-10 Schering Corporation Substituted piperidines that increase p53 activity and the uses thereof
US7638548B2 (en) * 2006-11-09 2009-12-29 Hoffmann-La Roche Inc. Spiroindolinone derivatives
WO2008080822A1 (en) 2006-12-29 2008-07-10 F. Hoffmann-La Roche Ag Epimerization methodologies for recovering stereo isomers in high yield and purity
US7553833B2 (en) * 2007-05-17 2009-06-30 Hoffmann-La Roche Inc. 3,3-spiroindolinone derivatives

Also Published As

Publication number Publication date
US7928233B2 (en) 2011-04-19
SG173591A1 (en) 2011-09-29
CN102264738A (zh) 2011-11-30
WO2010091979A1 (en) 2010-08-19
EP2396326A1 (en) 2011-12-21
CA2751243A1 (en) 2010-08-19
US20100204257A1 (en) 2010-08-12
JP2012512849A (ja) 2012-06-07
AU2010212995A1 (en) 2011-06-23
MX2011007886A (es) 2011-08-15
KR20110100678A (ko) 2011-09-14
IL213466A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
BRPI1006113A2 (pt) "derivado de piridina".
BRPI0810202A2 (pt) Derivados de piridina
BR112012000763A2 (pt) derivados de piridin-4-ila
BR112012012872A2 (pt) "pirrolindinas de espiroindolinona"
BRPI1013246A2 (pt) derivados de benzofuralina
BR112012002828A2 (pt) derivados de 5-fluorpirimidinona
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0817935A2 (pt) Derivados de biarila
EP2511268A4 (en) oxazine
BR112012015868A2 (pt) derivados de imidazolidinadiona
ECSP12011999A (es) Derivados benzamida sustituidos
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
BRPI1013844A2 (pt) derivados de piridina-isoxazol
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
EP2444395A4 (en) SUBSTITUTED ISOCHINOLINE DERIVATIVE
DK2397480T3 (da) Diazepindionderivat
BRPI1014454A2 (pt) derivados de isoxazol-pirazol
BRPI0906357A2 (pt) Derivados de oxazepinopirimidona arilamida substituídos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]